← All stocks

FILANA THERAPEUTICS, INC.

FLNA Net buying

CIK 0001069530 #4748 in the set updated 18 Sep 2026

Bought (120 mo)

$11.19M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$2.20M

$0.00 on a plan · $238.47K straight out of an exercise

Sold at will

$1.96M

13 of 15 sales

Net

+$8.99M

+$9.23M against sales at will

By person

12 insiders · 81 transactions

4.0×

Richard J. Barry holds only 4.0 times base salary in stock. $2.72M of shares against $675.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Richard J. Barry last reported holding, valued at $2.90, the price Common Stock was last bought or sold at on the open market here, on 24 Nov 2025.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

ROBERTSON SANFORD

Director

$5.59M (10)

—

+$5.59M

955,851

1.98%

$2.77M

—

Barry Richard

President & CEO

$4.63M (12)

—

+$4.63M

938,060

1.94%

$2.72M

+525.4%

ARMISTICE CAPITAL, LLC entity

10% owner

—

$1.95M (12)

−$1.95M

1,651,340

3.42%

$4.79M

−51.7%

BARBIER REMI

President & CEO

$694.69K (4)

—

+$694.69K

2,410,638

4.99%

$6.99M

+9.8%

Schoen Eric

Chief Financial Officer

$154.82K (5)

$238.47K (2) scheduled

−$83.65K

38,800

0.0803%

$112.52K

+101.0%

Kupiec James William

Chief Medical Officer

$61.10K (1)

$15.48K (1)

+$45.62K

0.0000%

$0.00

—

Cook Robert Christopher

Chief Operating & Legal Office

$39.94K (1)

—

+$39.94K

13,725

0.0284%

$39.80K

—

Anderson Robert Eugene Jr

Director

$24.94K (1)

—

+$24.94K

8,600

0.0178%

$24.94K

—

FRIEDMANN NADAV

Chief Medical Officer

—

79,910

0.1654%

$231.74K

+26.7%

GUSSIN ROBERT Z

Director

—

10,617

0.0220%

$30.79K

—

O DONNELL MICHAEL J

Director

—

6,873

0.0142%

$19.93K

+49.8%

SCANNON PATRICK J MD PHD

Director

—

1,000

0.0021%

$2.90K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Schoen Eric

29 Nov 2024

Chief Financial Officer

Sold after exercise

59,800

$3.86

$230.83K

Schoen Eric

29 Nov 2024

Chief Financial Officer

Sold after exercise indirect

2,000

$3.82

$7.64K

Show all 81 transactions →

What was left out

Form 4 filings counted 128

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 2

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 2

Sales at will 13

Transactions with no price 0

Shares from compensation/vesting 926,347

Sales filed before the plan box existed 12

History held since 5 May 2017